AU4817200A - Death domain containing receptor 5 - Google Patents

Death domain containing receptor 5

Info

Publication number: AU4817200A
Authority: AU; Australia
Prior art keywords: domain containing; death domain; containing receptor; receptor; death
Prior art date: 1999-05-04
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU48172/00A

Inventor

Reiner L Gentz

Jian Ni

Craig A Rosen

Guo-Liang Yu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Human Genome Sciences Inc

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-04

Filing date

2000-05-04

Publication date

2000-11-17

2000-05-04 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

2000-11-17 Publication of AU4817200A publication Critical patent/AU4817200A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Microbiology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Cell Biology (AREA)
Toxicology (AREA)
Zoology (AREA)
Communicable Diseases (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Investigating Or Analysing Biological Materials (AREA)

AU48172/00A 1999-05-04 2000-05-04 Death domain containing receptor 5 Abandoned AU4817200A (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US13249899P	1999-05-04	1999-05-04
US60132498		1999-05-04
US13323899P	1999-05-07	1999-05-07
US60133238		1999-05-07
US14893999P	1999-08-13	1999-08-13
US60148939		1999-08-13
PCT/US2000/012041 WO2000066156A1 (en)	1999-05-04	2000-05-04	Death domain containing receptor 5

Publications (1)

Publication Number	Publication Date
AU4817200A true AU4817200A (en)	2000-11-17

Family

ID=27384298

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU48172/00A Abandoned AU4817200A (en)	1999-05-04	2000-05-04	Death domain containing receptor 5

Country Status (5)

Country	Link
EP (1)	EP1196191A4 (en)
JP (1)	JP2002543151A (en)
AU (1)	AU4817200A (en)
CA (1)	CA2369371A1 (en)
WO (1)	WO2000066156A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7528239B1 (en)	1997-02-13	2009-05-05	Immunex Corporation	Receptor that binds trail
US6342369B1 (en)	1997-05-15	2002-01-29	Genentech, Inc.	Apo-2-receptor
US7279160B2 (en)	2000-05-02	2007-10-09	The Uab Research Foundation	Combinations of DR5 antibodies and other therapeutic agents
TWI318983B (en)	2000-05-02	2010-01-01	Uab Research Foundation	An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
US7476383B2 (en)	2000-05-02	2009-01-13	The Uab Research Foundation	Antibody selective for DR4 and uses thereof
US7115717B2 (en)	2001-05-18	2006-10-03	Kirin Beer Kabushiki Kaisha	Anti-TRAIL-R antibodies
CA2446723C (en)	2001-05-25	2014-01-21	Human Genome Sciences, Inc.	Antibodies that immunospecifically bind to trail receptors
JPWO2003038087A1 (en)	2001-10-04	2005-02-24	関西ティー・エル・オー株式会社	Promoter of DR5 gene and promoter of Siah-1 gene
PL1606318T3 (en) *	2003-03-26	2010-01-29	Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts	Improved fc fusion proteins
NZ550518A (en)	2004-03-23	2009-11-27	Biogen Idec Inc	Agents that cross link TNF receptors for treating cancer
WO2005114187A2 (en) *	2004-04-23	2005-12-01	The United States Of America As Represented By Thesecretary, Department Of Health And Human Services	Methods and compositions for diagnosing aids and other diseases and conditions involving immune system activation
EP1846034A4 (en)	2005-02-02	2010-11-10	Uab Research Foundation	AGENTS AND METHODS FOR REDUCING AGONIST RESISTANCE OF APOPTOSIS-INDUCING DEATH RECEPTORS
PE20071101A1 (en)	2005-08-31	2007-12-21	Amgen Inc	POLYPEPTIDES AND ANTIBODIES
EP2496606A2 (en)	2009-11-05	2012-09-12	The UAB Research Foundation	Treating basal-like genotype cancers
WO2011116344A2 (en)	2010-03-18	2011-09-22	The Uab Research Foundation	Targeting cancer stem cells
JP6219923B2 (en) *	2012-03-28	2017-10-25	アムジェンインコーポレイテッド	Combination of DR5 receptor agonists
SMT201700530T1 (en)	2013-03-14	2018-01-11	Bristol Myers Squibb Co	Combination of dr5 agonist and anti-pd-1 antagonist and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010010924A1 (en) *	1997-03-14	2001-08-02	Keith Charles Deen	Tumor necrosis factor related receptor, tr6 polynecleotides
AU747635B2 (en) *	1997-03-17	2002-05-16	Human Genome Sciences, Inc.	Death domain containing receptor 5
EP2213302A3 (en) *	1999-05-28	2010-11-03	Genentech, Inc.	DR4 antibodies and uses thereof
JP2003505344A (en) *	1999-06-09	2003-02-12	ジェネンテック・インコーポレーテッド	Synergistic effect of Apo-2L receptor agonist and CPT-11
TWI318983B (en) *	2000-05-02	2010-01-01	Uab Research Foundation	An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof

2000
- 2000-05-04 EP EP00930329A patent/EP1196191A4/en not_active Withdrawn
- 2000-05-04 AU AU48172/00A patent/AU4817200A/en not_active Abandoned
- 2000-05-04 JP JP2000615040A patent/JP2002543151A/en active Pending
- 2000-05-04 WO PCT/US2000/012041 patent/WO2000066156A1/en active Search and Examination
- 2000-05-04 CA CA002369371A patent/CA2369371A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2000066156A8 (en)	2001-07-26
CA2369371A1 (en)	2000-11-09
EP1196191A4 (en)	2004-03-24
JP2002543151A (en)	2002-12-17
WO2000066156A1 (en)	2000-11-09
EP1196191A1 (en)	2002-04-17

Publication	Publication Date	Title
AU5546000A (en)	2001-01-02	Compounds
AU4318000A (en)	2000-12-05	Agarobiose-containing composition
AU4817200A (en)	2000-11-17	Death domain containing receptor 5
AU1290501A (en)	2001-06-04	Composition
AU4984300A (en)	2000-11-21	Death domain containing receptor 4
AU4478200A (en)	2000-11-10	Death domain containing receptors
AU1746401A (en)	2001-06-06	Compounds
AU3997700A (en)	2000-10-04	Anti-first-pass effect compounds
AU7789800A (en)	2001-04-30	Stable multiple emulsion composition
AU6277699A (en)	2000-09-21	Guarantee 20
AU4543300A (en)	2000-11-14	Sunscreen agents
AU2676001A (en)	2001-07-16	Fire-protection device
AU6310600A (en)	2001-02-05	Composition
AU6567400A (en)	2001-03-05	Substituted 2-imino-thiazolines
AU5567600A (en)	2001-01-09	Hairdye composition
AU2028401A (en)	2001-06-18	3-methyl-chromane or thiochromane derivatives
AU2002300603A1 (en)	2003-02-13	Death Domain Containing Receptor 5
AU6610500A (en)	2001-02-19	Antidiscoloration composition
AU2668000A (en)	2000-08-29	Bis-styrylbiphenyl compounds
AU5119400A (en)	2000-12-18	Compounds
AUPQ413599A0 (en)	1999-12-09	Anti-fouling composition
AU6831100A (en)	2001-03-05	Substituted heterocyclybenzofuranes
EP1161453A4 (en)	2005-01-05	Cytokine-binding domain
AU1539901A (en)	2001-06-12	Composition
AU3045700A (en)	2000-09-28	Insecticide composition

Legal Events

Date	Code	Title	Description
2002-03-21	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase